Neurology Central

Neuroblastoma detected by novel biomarker assay with increased sensitivity

New research from The Saban Research Institute of Children’s Hospital Los Angeles (CHLA) (CA, US), has resulted in the development and testing of a novel biomarker assay that detects the presence of neuroblastoma as well as quantifying disease, even in cases where standard evaluations yield negative results.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.